Therapeutic efficacy of hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a propensity score matching study.

ABSTRACT:

Background

Hepatic resection(HR) and radiofrequency ablation(RFA) are widely used for recurrent hepatocellular carcinoma(RHCC), yet their therapeutic efficacy remains debated. This study aimed to compare outcomes of HR versus RFA in RHCC patients within Milan Criteria.

Methods

This was a retrospective single-center study of patients with HCC recurrence after initial radical hepatectomy for primary liver cancer, meeting Milan criteria for recurrence. Patients underwent HR (n = 128) or RFA (n = 134) at West China Hospital of Sichuan University between January 2015 and August 2019. The final follow-up date for this study was August 31, 2022. Propensity score matching (1:1 ratio) was applied to balance baseline characteristics. Clinical outcomes were analyzed before and after ma

SUBMITTER: Cao J 

PROVIDER: S-EPMC12557961 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature